Andrey A. Novak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrey A. Novak has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Yuriy L. Mizernitskiy
Pirogov Russian National Research Medical University
10 shared publications Ю. Л. Мизерницкий
Научно-исследовательский клинический институт педиатрии и детской хирургии имени академика Ю.Е. Вельтищева Российского национального исследовательского медицинского университета имени Н.И. Пирогова; Российский национальный исследовательский медицинский университет имени Н.И. Пирогова
10 shared publications- Amina R. Shudueva
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
3 shared publications - E. S. Ryngachenko
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
2 shared publications - Lyudmila Sokolova
Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University
2 shared publications - P. A. Shatokha
Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 234-243
Clinical efficacy and safety of long-term anti-inflammatory therapy with azithromycin in children with primary ciliary dyskinesia
Introduction. Long-term anti-inflammatory therapy with azithromycin in children with primary ciliary dyskinesia (PCD) reduces the frequency of exacerbations and improves the course of the disease, but it may be associated with the development of adverse effects. Aim . To evaluate the clinical efficacy and safety of long-term anti-inflammatory therapy with azithromycin in children with PCD. Materials and methods . The study included 99 children with PCD aged 2 to 18 years. The children were divided into groups: Group 1 (n = 32) included children who received azithromycin therapy for 1 year, Group 2 (n = 19) included children who received therapy for more than 2 years, and Group 3 (n = 48) included children who did not receive azithromycin therapy. The frequency of exacerbations, markers of inflammation (CRP, leukocytes, neutrophils), renal-hepatic profile (cholesterol, urea, creatinine, AST, ALT, alkaline phosphatase, total bilirubin, direct and indirect bilirubin), QT interval on ECG, and bacteriological cultures from the nose and throat with determination of sensitivity to azithromycin were evaluated. Results . Anti-inflammatory therapy with azithromycin significantly reduced the frequency of exacerbations: by 2.2 times in the first year (from 6.2 to 2.8 episodes/year) and by 1.6 times in treatment for more than 2 years (from 3.4 to 2.1 episodes/year) and the CRP level (p < 0.05). No deviations were observed in biochemical parameters and the QT interval (p > 0.05). However, an increase in antibiotic resistance was detected: the sensitivity of S. aureus decreased, and S. pneumoniae was completely resistant after more than 2 years of therapy. Conclusions . Long-term therapy with azithromycin is effective in children with PCD, significantly reducing the frequency of exacerbations and the activity of inflammation, with a favorable safety profile. However, it is associated with the progressive development of resistance to key respiratory pathogens, which requires a strictly individualized approach, dynamic microbiological monitoring, and a balance between benefits and risks for each child.
- 24 March 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 234-243
Open AccessClinical efficacy and safety of long-term anti-inflammatory therapy with azithromycin in children with primary ciliary dyskinesia
Introduction. Long-term anti-inflammatory therapy with azithromycin in children with primary ciliary dyskinesia (PCD) reduces the frequency of exacerbations and improves the course of the disease, but it may be associated with the development of adverse effects. Aim . To evaluate the clinical efficacy and safety of long-term anti-inflammatory therapy with azithromycin in children with PCD. Materials and methods . The study included 99 children with PCD aged 2 to 18 years. The children were divided into groups: Group 1 (n = 32) included children who received azithromycin therapy for 1 year, Group 2 (n = 19) included children who received therapy for more than 2 years, and Group 3 (n = 48) included children who did not receive azithromycin therapy. The frequency of exacerbations, markers of inflammation (CRP, leukocytes, neutrophils), renal-hepatic profile (cholesterol, urea, creatinine, AST, ALT, alkaline phosphatase, total bilirubin, direct and indirect bilirubin), QT interval on ECG, and bacteriological cultures from the nose and throat with determination of sensitivity to azithromycin were evaluated. Results . Anti-inflammatory therapy with azithromycin significantly reduced the frequency of exacerbations: by 2.2 times in the first year (from 6.2 to 2.8 episodes/year) and by 1.6 times in treatment for more than 2 years (from 3.4 to 2.1 episodes/year) and the CRP level (p < 0.05). No deviations were observed in biochemical parameters and the QT interval (p > 0.05). However, an increase in antibiotic resistance was detected: the sensitivity of S. aureus decreased, and S. pneumoniae was completely resistant after more than 2 years of therapy. Conclusions . Long-term therapy with azithromycin is effective in children with PCD, significantly reducing the frequency of exacerbations and the activity of inflammation, with a favorable safety profile. However, it is associated with the progressive development of resistance to key respiratory pathogens, which requires a strictly individualized approach, dynamic microbiological monitoring, and a balance between benefits and risks for each child.
- 28 August 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (4) , 58–64
Characteristics of neuropsychological disorders in children with primary ciliary dyskinesia and bronchial asthma
The group of chronic non-specific lung diseases in children has not yet been sufficiently studied in terms of their impact on mental development, with the exception of bronchial asthma, for which there are a number of studies in the context of psychosomatic disorders. Meanwhile, the use of a neuropsychological approach in conducting topical psychological diagnostics in children may also be of practical importance from the point of view of choosing the directions of differentiated psychological correction. The aim of the study: to determine the nature of neuropsychological disorders in children with primary ciliary dyskinesia in comparison with patients with bronchial asthma.Materials and methods. The work was carried out at the Pulmonology Department of the Veltischev Institute and at the Department of Innovative Pediatrics and Pediatric Surgery of the Pirogov University of the Ministry of Health of the Russian Federation. The study included 60 children with chronic non-specific lung diseases, divided into 2 groups: Group 1 (main) (n=30) — children suffering from primary ciliary dyskinesia (6 girls and 24 boys); Group 2 (comparison) (n=30) — children suffering from bronchial asthma (16 girls and 14 boys). The age of the examined children was (group 1/2): 6–8 years — 6/4; 9–12 years — 13/11; 13–17 years — 11/15 people. All children underwent a comprehensive assessment of the state of higher mental functions using the neuropsychological research method developed by A.R. Luria. Statistical data processing was performed using the Statistics software package SPSS.Results. During the study, a number of differences were identified in children: in primary ciliary dyskinesia, there was topical insufficiency of the right hemisphere of the brain, while bronchial asthma is characterized by an increase in the functional state of the left hemisphere.Conclusions. Children with bronchial asthma are generally characterized by increased functional activity of the left hemisphere. Children with primary ciliary dyskinesia have a deficit in the holistic strategy of information processing, which is the prerogative of the right hemisphere. This may have practical significance in developing individual programs of neuropsychological correctional and developmental training.
- 28 August 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (4) , 58–64
Characteristics of neuropsychological disorders in children with primary ciliary dyskinesia and bronchial asthma
The group of chronic non-specific lung diseases in children has not yet been sufficiently studied in terms of their impact on mental development, with the exception of bronchial asthma, for which there are a number of studies in the context of psychosomatic disorders. Meanwhile, the use of a neuropsychological approach in conducting topical psychological diagnostics in children may also be of practical importance from the point of view of choosing the directions of differentiated psychological correction. The aim of the study: to determine the nature of neuropsychological disorders in children with primary ciliary dyskinesia in comparison with patients with bronchial asthma.Materials and methods. The work was carried out at the Pulmonology Department of the Veltischev Institute and at the Department of Innovative Pediatrics and Pediatric Surgery of the Pirogov University of the Ministry of Health of the Russian Federation. The study included 60 children with chronic non-specific lung diseases, divided into 2 groups: Group 1 (main) (n=30) — children suffering from primary ciliary dyskinesia (6 girls and 24 boys); Group 2 (comparison) (n=30) — children suffering from bronchial asthma (16 girls and 14 boys). The age of the examined children was (group 1/2): 6–8 years — 6/4; 9–12 years — 13/11; 13–17 years — 11/15 people. All children underwent a comprehensive assessment of the state of higher mental functions using the neuropsychological research method developed by A.R. Luria. Statistical data processing was performed using the Statistics software package SPSS.Results. During the study, a number of differences were identified in children: in primary ciliary dyskinesia, there was topical insufficiency of the right hemisphere of the brain, while bronchial asthma is characterized by an increase in the functional state of the left hemisphere.Conclusions. Children with bronchial asthma are generally characterized by increased functional activity of the left hemisphere. Children with primary ciliary dyskinesia have a deficit in the holistic strategy of information processing, which is the prerogative of the right hemisphere. This may have practical significance in developing individual programs of neuropsychological correctional and developmental training.
- 10 May 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (2) , 86-91
Reversibility of bronchial obstruction in patients with primary ciliary dyskinesia to justify correction of inhalation therapy
Purpose. To assess the reversibility of bronchial obstruction in patients with primary ciliary dyskinesia in groups with and without concomitant allergic inflammation, with the aim of a differentiated approach to inhalation therapy and the validity of prescribing bronchodilators.Material and methods. Retrospective analysis of the results of FEV1 before and after inhalation of a bronchodilator and study of the dependence of the reversibility of obstruction on the presence of atopy markers.Results. Of 100 patients, 63% (n=63) had atopy markers; 37% (n=37) did not have these markers (p≤0.05). When comparing the FEV1 indicator in children with the presence of allergic burden (n=63) and in the absence of it (n=37), it was found that in patients with markers of atopy, obstructive changes identified during spirometry were 14.2% more common ( p≤0.05). Reversibility of bronchial obstruction was recorded in 24% (n=24), of which 87.5% (n=21) of patients had markers of atopy (p≤0.05). In children with concomitant allergic burden and a decrease in FEV1, reversibility of obstruction was detected in 48.4% (n=15) of cases (p≤0.05). It was revealed that in patients with the presence of atopy markers and a decrease in FEV1≤80%, reversibility of obstruction occurs 42.8% more often compared to the group of patients with a normal level of FEV1 (p≤0.05).Conclusions. The vast majority of patients with primary ciliary dyskinesia (n=63) have markers of atopy, mainly due to an isolated increase in total IgE in the blood serum (p≤0.05). A decrease in FEV1≤80% in children with allergies was detected 14.2% more often compared to the group of children without it (p≤0.05). In the vast majority of patients with an allergic phenotype, reversibility of obstruction was observed after a test with a bronchodilator. Thus, all patients with primary ciliary dyskinesia and the presence of atopy markers are recommended to undergo a test with a bronchodilator, and if reversibility of obstruction is detected, it is advisable to add a bronchodilator drug to therapy.
- 10 May 2024
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 69 (2) , 86-91
Reversibility of bronchial obstruction in patients with primary ciliary dyskinesia to justify correction of inhalation therapy
Purpose. To assess the reversibility of bronchial obstruction in patients with primary ciliary dyskinesia in groups with and without concomitant allergic inflammation, with the aim of a differentiated approach to inhalation therapy and the validity of prescribing bronchodilators.Material and methods. Retrospective analysis of the results of FEV1 before and after inhalation of a bronchodilator and study of the dependence of the reversibility of obstruction on the presence of atopy markers.Results. Of 100 patients, 63% (n=63) had atopy markers; 37% (n=37) did not have these markers (p≤0.05). When comparing the FEV1 indicator in children with the presence of allergic burden (n=63) and in the absence of it (n=37), it was found that in patients with markers of atopy, obstructive changes identified during spirometry were 14.2% more common ( p≤0.05). Reversibility of bronchial obstruction was recorded in 24% (n=24), of which 87.5% (n=21) of patients had markers of atopy (p≤0.05). In children with concomitant allergic burden and a decrease in FEV1, reversibility of obstruction was detected in 48.4% (n=15) of cases (p≤0.05). It was revealed that in patients with the presence of atopy markers and a decrease in FEV1≤80%, reversibility of obstruction occurs 42.8% more often compared to the group of patients with a normal level of FEV1 (p≤0.05).Conclusions. The vast majority of patients with primary ciliary dyskinesia (n=63) have markers of atopy, mainly due to an isolated increase in total IgE in the blood serum (p≤0.05). A decrease in FEV1≤80% in children with allergies was detected 14.2% more often compared to the group of children without it (p≤0.05). In the vast majority of patients with an allergic phenotype, reversibility of obstruction was observed after a test with a bronchodilator. Thus, all patients with primary ciliary dyskinesia and the presence of atopy markers are recommended to undergo a test with a bronchodilator, and if reversibility of obstruction is detected, it is advisable to add a bronchodilator drug to therapy.
- Open Access
- 6 March 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (2) , 176-183
Parallels between clinical and genetic characteristics in children with primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is a rare genetic disorder that leads to chronic inflammatory damage to the airways and auditory organs. This article presents current information and a study aimed at investigating parallels between the course of PCD and clinical and genetic variant of the disease, which contributes to a timely diagnosis and enables personalized treatment approach.The aim of the study was to identify phenotypic characteristics and chronological patterns of PCD course depending on the genotype.Methods. The study was conducted at the Veltischev Research Clinical Institute of Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of Russia. The study included children with PCD who underwent next generation sequencing (NGS) of the exome.Results. Significant differences were found in the course of PCD based on clinical and genetic characteristics. Children with defects in the genes encoding central pair proteins are characterized by an earlier onset of daily productive cough and recurrent respiratory infections. A similar pattern is typical for patients with defects in the genes encoding the cilia assembly proteins. The first episode of respiratory infection occurs later in patients with defects in the genes encoding dynein handle proteins. Patients who do not have defects in PCD-associated genes are characterized by a late onset of persistent difficulty in nasal breathing, productive cough and respiratory diseases.Conclusion. Identification of clinical and genetic variants of PCD allows prediction of chronological features of the course of the disease.
- 6 March 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (2) , 176-183
Open AccessParallels between clinical and genetic characteristics in children with primary ciliary dyskinesia
Primary ciliary dyskinesia (PCD) is a rare genetic disorder that leads to chronic inflammatory damage to the airways and auditory organs. This article presents current information and a study aimed at investigating parallels between the course of PCD and clinical and genetic variant of the disease, which contributes to a timely diagnosis and enables personalized treatment approach.The aim of the study was to identify phenotypic characteristics and chronological patterns of PCD course depending on the genotype.Methods. The study was conducted at the Veltischev Research Clinical Institute of Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University (Pirogov Medical University), Ministry of Health of Russia. The study included children with PCD who underwent next generation sequencing (NGS) of the exome.Results. Significant differences were found in the course of PCD based on clinical and genetic characteristics. Children with defects in the genes encoding central pair proteins are characterized by an earlier onset of daily productive cough and recurrent respiratory infections. A similar pattern is typical for patients with defects in the genes encoding the cilia assembly proteins. The first episode of respiratory infection occurs later in patients with defects in the genes encoding dynein handle proteins. Patients who do not have defects in PCD-associated genes are characterized by a late onset of persistent difficulty in nasal breathing, productive cough and respiratory diseases.Conclusion. Identification of clinical and genetic variants of PCD allows prediction of chronological features of the course of the disease.
- Open Access
- 13 April 2023
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 33 (2) , 251-258
A rare variant of primary ciliary dyskinesia in combination with hereditary hemorrhagic telangiectasia type 1: a case from practice
Primary ciliary dyskinesia (PCD) is a rare genetic disease belonging to the group of ciliopathies. The disease develops because a defect in the ultrastructure of the epithelial cilia in the respiratory tract and similar structures (sperm flagella, villi of the fallopian tubes, ventricular ependyma, etc.) disturbs their motor function. Currently, various clinical and genetic variants of the disease are distinguished, increasing the effectiveness of dynamic examination and treatment.Aim. In this article, we describe a patient with a rare variant of PCD that we identified in combination with a mutation in the ENG gene responsible for the development of hereditary hemorrhagic telangiectasia type 1 (HHT-1). HHT-1 is a rare hereditary disease that manifests as various vascular dysplasias, including arteriovenous malformations (AVM) in the lungs, which can significantly worsen the course of the disease and be a predictor of an unfavorable outcome.Conclusion. The presented case demonstrates a combination of two rare genetic diseases in a child. The uniqueness of the case also lies in the fact that the identified rare mutation in the DRC1 gene responsible for the development of PCD is not associated with a loss of motility of the cilia of the ciliated epithelium, which makes the testing and the correct diagnosis even more difficult.
- 13 April 2023
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 33 (2) , 251-258
Open AccessA rare variant of primary ciliary dyskinesia in combination with hereditary hemorrhagic telangiectasia type 1: a case from practice
Primary ciliary dyskinesia (PCD) is a rare genetic disease belonging to the group of ciliopathies. The disease develops because a defect in the ultrastructure of the epithelial cilia in the respiratory tract and similar structures (sperm flagella, villi of the fallopian tubes, ventricular ependyma, etc.) disturbs their motor function. Currently, various clinical and genetic variants of the disease are distinguished, increasing the effectiveness of dynamic examination and treatment.Aim. In this article, we describe a patient with a rare variant of PCD that we identified in combination with a mutation in the ENG gene responsible for the development of hereditary hemorrhagic telangiectasia type 1 (HHT-1). HHT-1 is a rare hereditary disease that manifests as various vascular dysplasias, including arteriovenous malformations (AVM) in the lungs, which can significantly worsen the course of the disease and be a predictor of an unfavorable outcome.Conclusion. The presented case demonstrates a combination of two rare genetic diseases in a child. The uniqueness of the case also lies in the fact that the identified rare mutation in the DRC1 gene responsible for the development of PCD is not associated with a loss of motility of the cilia of the ciliated epithelium, which makes the testing and the correct diagnosis even more difficult.
- 1 March 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 68 (1) , 39-46
Clinical and genetic spectrum of primary ciliary dyskinesia in children
Primary ciliary dyskinesia is a rare genetically determined pathology that leads to chronic inflammatory damage to the respiratory tract, hearing organs and impaired fertility. This article presents the preliminary results of a study conducted in the clinic aimed at the possibility of predicting the clinical course of the disease depending on the genetic variants of the disease, which enables, with timely diagnosis, personalizing the approach to the treatment of children with such a disabling disease as primary ciliary dyskinesia.Purpose. To determine the clinical and genetic variants of primary ciliary dyskinesia, and to identify patterns of disease development. Material and methods. The study included children from 0 to 18 years old with a verified defect of the ciliary apparatus, by analyzing the mobility of the cilia of the ciliary epithelium of the mucous membrane of the respiratory tract, and who underwent a next generation sequencing exome study.Results. The study revealed characteristic patterns of target organ damage, prevailing in a group of children with impaired cilia assembly factor, as well as in a group of children with damaged dynein arms.Conclusion. Thus, conducting a genetic examination in children with suspected primary ciliary dyskinesia is relevant not only to confirm the disease, but also to predict the course of the disease.
- 1 March 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 68 (1) , 39-46
Clinical and genetic spectrum of primary ciliary dyskinesia in children
Primary ciliary dyskinesia is a rare genetically determined pathology that leads to chronic inflammatory damage to the respiratory tract, hearing organs and impaired fertility. This article presents the preliminary results of a study conducted in the clinic aimed at the possibility of predicting the clinical course of the disease depending on the genetic variants of the disease, which enables, with timely diagnosis, personalizing the approach to the treatment of children with such a disabling disease as primary ciliary dyskinesia.Purpose. To determine the clinical and genetic variants of primary ciliary dyskinesia, and to identify patterns of disease development. Material and methods. The study included children from 0 to 18 years old with a verified defect of the ciliary apparatus, by analyzing the mobility of the cilia of the ciliary epithelium of the mucous membrane of the respiratory tract, and who underwent a next generation sequencing exome study.Results. The study revealed characteristic patterns of target organ damage, prevailing in a group of children with impaired cilia assembly factor, as well as in a group of children with damaged dynein arms.Conclusion. Thus, conducting a genetic examination in children with suspected primary ciliary dyskinesia is relevant not only to confirm the disease, but also to predict the course of the disease.
- 8 January 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (6) , 88-92
Rare variant of heterotaxy syndrome in childhood in pulmonology clinic
Heterotaxy syndrome is a congenital malformation in which the internal organs of the chest and abdominal cavity have an abnormal location. People suffering from this syndrome have multiple complex defects in the heart, blood vessels, spleen, liver, lungs and other organs. Heterotaxy is a rare pathology that requires a multidisciplinary approach to diagnosis. This article demonstrates a rare case of heterotaxy observed in the pulmonology clinic of the Veltischev Institute.
- 8 January 2023
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (6) , 88-92
Rare variant of heterotaxy syndrome in childhood in pulmonology clinic
Heterotaxy syndrome is a congenital malformation in which the internal organs of the chest and abdominal cavity have an abnormal location. People suffering from this syndrome have multiple complex defects in the heart, blood vessels, spleen, liver, lungs and other organs. Heterotaxy is a rare pathology that requires a multidisciplinary approach to diagnosis. This article demonstrates a rare case of heterotaxy observed in the pulmonology clinic of the Veltischev Institute.
- Open Access
- 12 July 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 36-39
Experience of inhaled hypertonic saline use in pediatric pulmonology
Impaired secretion and removal of mucus from the respiratory tract are important pathophysiological links in the development of several pulmonary pathologies: chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, cystic pulmonary fibrosis, etc. In the article, modern approaches to the use of inhaled hypertonic (3-7%) sodium chloride solutions in children with various recurrent and chronic bronchopulmonary pathologies are analysed. The combination of hypertonic sodium chloride solution and hyaluronic acid can minimize the unpleasant effects of hypertonic solution, such as irritating cough caused by the effect of salt on the cough receptors of the upper respiratory tract. At the same time, hyaluronic acid has unique water-retaining properties, therefore it plays an important role in regulating the fluid balance in the lung interstitium, moistens the airways, reduces bronchial hyperresponsiveness, decreases inflammation and destroys the biofilm associated with chronic infection. The use of nebulizer inhalations with a combination drug containing hypertonic sodium chloride solution and hyaluronic acid has proved to be successful in pulmonological pediatric practice. The authors have learned first-hand that this combination is highly efficient. The described clinical cases demonstrate the positive experience of inhaled use of the domestic combination drug of 3% hypertonic sodium chloride solution and hyaluronic acid in the treatment of preschool patients (5 years old) with the following diagnoses: recurrent bronchitis, primary ciliary dyskinesia (Kartagener's syndrome). This inhalation therapy helped not only to improve the rheological properties of sputum, quickly restore the bronchi to health, reduce signs of inflammation of the respiratory tract, but also generally improve the patients' breathing and quality of life.
- 12 July 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 36-39
Open AccessExperience of inhaled hypertonic saline use in pediatric pulmonology
Impaired secretion and removal of mucus from the respiratory tract are important pathophysiological links in the development of several pulmonary pathologies: chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, cystic pulmonary fibrosis, etc. In the article, modern approaches to the use of inhaled hypertonic (3-7%) sodium chloride solutions in children with various recurrent and chronic bronchopulmonary pathologies are analysed. The combination of hypertonic sodium chloride solution and hyaluronic acid can minimize the unpleasant effects of hypertonic solution, such as irritating cough caused by the effect of salt on the cough receptors of the upper respiratory tract. At the same time, hyaluronic acid has unique water-retaining properties, therefore it plays an important role in regulating the fluid balance in the lung interstitium, moistens the airways, reduces bronchial hyperresponsiveness, decreases inflammation and destroys the biofilm associated with chronic infection. The use of nebulizer inhalations with a combination drug containing hypertonic sodium chloride solution and hyaluronic acid has proved to be successful in pulmonological pediatric practice. The authors have learned first-hand that this combination is highly efficient. The described clinical cases demonstrate the positive experience of inhaled use of the domestic combination drug of 3% hypertonic sodium chloride solution and hyaluronic acid in the treatment of preschool patients (5 years old) with the following diagnoses: recurrent bronchitis, primary ciliary dyskinesia (Kartagener's syndrome). This inhalation therapy helped not only to improve the rheological properties of sputum, quickly restore the bronchi to health, reduce signs of inflammation of the respiratory tract, but also generally improve the patients' breathing and quality of life.
- 8 April 2022
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (1) , 125-131
Clinical features of bronchial asthma in children with mental disorders
The article discusses the role of the central nervous system, including mental disorders, in bronchial asthma in children. This problem has been of interest to practicing pediatricians and researchers for a long time, but so far it has not had unambiguous solutions. The authors have a diverse approach to its assessment, leaning towards the modern concept of ‘psychopathological’ or ‘psychological’ diathesis put forward by S.Yu. Tsyrkin. On specific clinical examples, the authors clearly demonstrated the influence of mental disorders on the course of bronchial asthma in children, which, of course, must be taken into account in practical work by pediatric pulmonologists.
- 8 April 2022
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (1) , 125-131
Clinical features of bronchial asthma in children with mental disorders
The article discusses the role of the central nervous system, including mental disorders, in bronchial asthma in children. This problem has been of interest to practicing pediatricians and researchers for a long time, but so far it has not had unambiguous solutions. The authors have a diverse approach to its assessment, leaning towards the modern concept of ‘psychopathological’ or ‘psychological’ diathesis put forward by S.Yu. Tsyrkin. On specific clinical examples, the authors clearly demonstrated the influence of mental disorders on the course of bronchial asthma in children, which, of course, must be taken into account in practical work by pediatric pulmonologists.
- Open Access
- 21 March 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 276-285
Primary ciliary dyskinesia: state of the problem and prospects
This review article provides an up-to-date understanding of primary ciliary dyskinesia (immotile-cilia syndrome) and its particular variant, Cartagener syndrome, a genetically determined pathology leading to chronic inflammatory lesions of the respiratory tract, hearing organs, and impaired fertile function. This orphan disease is not well known to the general medical community. Primary ciliary dyskinesia is a rare hereditary disease of the group of ciliopathies that is based on a genetically determined defect in the ultrastructure of the cilia of the respiratory tract epithelium and similar structures, leading to impaired motor function. Various step-by-step algorithms have been proposed to verify the diagnosis, the obligatory components of which are assessment of the motor ability of the cilia of the atopic epithelium, nasal nitric oxide (nNO) level, electron microscopic examination of a bronchial mucosal biopsy specimen, and genetic examination. There is no gold standard for diagnosis of primary ciliary dyskinesia. Diagnostic search in patients should be complex and consist of certain stages. Currently, therapeutic strategies for primary ciliary dyskinesia are based on approved clinical guidelines. In many countries, the therapy of patients with primary ciliary dyskinesia is based on treatment protocols for patients with cystic fibrosis, despite the obvious differences in these diseases. The main goal of therapy is adequate airway clearance, control and prevention of infectious diseases, and elimination of potential airway exposure to various types of pollutants, including tobacco smoke. The article describes the clinic, characteristic symptoms of the disease, its prevalence and genetic aspects, discusses the problems of diagnosis, treatment, prognosis and monitoring of these children, as well as the need for a national register of patients with this pathology.
- 21 March 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 276-285
Open AccessPrimary ciliary dyskinesia: state of the problem and prospects
This review article provides an up-to-date understanding of primary ciliary dyskinesia (immotile-cilia syndrome) and its particular variant, Cartagener syndrome, a genetically determined pathology leading to chronic inflammatory lesions of the respiratory tract, hearing organs, and impaired fertile function. This orphan disease is not well known to the general medical community. Primary ciliary dyskinesia is a rare hereditary disease of the group of ciliopathies that is based on a genetically determined defect in the ultrastructure of the cilia of the respiratory tract epithelium and similar structures, leading to impaired motor function. Various step-by-step algorithms have been proposed to verify the diagnosis, the obligatory components of which are assessment of the motor ability of the cilia of the atopic epithelium, nasal nitric oxide (nNO) level, electron microscopic examination of a bronchial mucosal biopsy specimen, and genetic examination. There is no gold standard for diagnosis of primary ciliary dyskinesia. Diagnostic search in patients should be complex and consist of certain stages. Currently, therapeutic strategies for primary ciliary dyskinesia are based on approved clinical guidelines. In many countries, the therapy of patients with primary ciliary dyskinesia is based on treatment protocols for patients with cystic fibrosis, despite the obvious differences in these diseases. The main goal of therapy is adequate airway clearance, control and prevention of infectious diseases, and elimination of potential airway exposure to various types of pollutants, including tobacco smoke. The article describes the clinic, characteristic symptoms of the disease, its prevalence and genetic aspects, discusses the problems of diagnosis, treatment, prognosis and monitoring of these children, as well as the need for a national register of patients with this pathology.